Cell Guidance Systems & Manchester Biogel launch 3D cell culture  

Cell Guidance Systems, a specialist in the control, manipulation, and monitoring of cells and biotech company Manchester Biogel have launched an adaptable environment for 3D cell culture. 

PODS-PeptiGels combines the benefits of two existing cell culture technologies – synthetic peptide hydrogels (PeptiGels) and a range of sustained release growth factors (PODS).  

PODS-PeptiGels incorporates Cell Guidance Systems’ POlyhedrin Delivery System (PODS) and Manchester BioGel’s biologically relevant hydrogels (PeptiGels). The kit enables researchers to mix and match over 70 growth factors, combined with hundreds of combinations of hydrogels, each with mechanical and biomimetic tuneability, to suit the aims of their research.  

PeptiGel hydrogel is produced using synthetic peptides reducing batch variations and enables reproducible results. The PODS crystal protects the growth factor cargo allowing sustained release over a longer period, thereby reducing the frequency of media changes required and minimising growth factor concentration cycles. 

Official comments 

 Dr Michael Jones, CEO of Cell Guidance Systems, said: “We are excited to launch PODS-PeptiGels with Manchester BIOGEL. Combining the benefits of PeptiGel and PODS technologies provides researchers with a simple and repeatable, physiologically relevant, cell matrix that produces consistent results in addition to reducing hands-on time.” 

Dr Donald Daley, CEO of Manchester BIOGEL, added: “Batch-to-batch variation of hydrogels is a big issue and our synthetic PeptiGels overcome this by eliminating variation making it easier to compare results. PeptiGels are functionalised synthetic platforms that support cell growth and are also free from animal origin. This combined with recombinant growth factors that do not degrade quickly due to the PODS technology from Cell Guidance Systems, makes for a powerful 3D cell culture solution that can be scaled up to high throughput, if required, whilst producing consistent and accurate results.” 

Suggested Reading

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free